How do the PLT-H (optical scatter) and PLT-O (fluorescence) platelet counting methods compare to the traditional impedance (PLT-I) method and manual microscopy?

Assessment of PLT-H and PLT-O Versus Traditional Impedance Method and Manual Microscopy in Platelet Counting

The hybrid platelet counting method (PLT-H) and optical fluorescence methods (PLT-O and PLT-F) demonstrate superior accuracy compared to traditional impedance (PLT-I) methods, particularly in samples with interfering substances such as small red blood cells, schistocytes, and in thrombocytopenic patients, with PLT-H offering the additional advantage of no extra cost over impedance methods.

Performance Hierarchy

PLT-H (Hybrid Method)

• Combines impedance with leukocyte differentiation channel measurements without additional reagent costs 1, 2
• Demonstrates excellent correlation with fluorescence methods (r = 0.991-0.999) across all platelet ranges 1
• In thrombocytopenic samples (PLT <50 G/L), reduces falsely elevated results by nearly fivefold compared to impedance 1
• Shows strong correlation with immunological reference method (PLT-IRM) at r = 0.993, with maintained accuracy (r = 0.963-0.992) under various interference conditions 2
• Coefficient of variation <7.6% in low-value samples (PLT <100 × 10⁹/L) regardless of interfering substances 2
• Performance remains stable with increasing levels of small RBCs, large platelets, and RBC fragments (P = 0.5704,0.0832,0.9893) 2

PLT-O and PLT-F (Optical/Fluorescence Methods)

• Utilize fluorescent nucleic acid staining and optical detection, providing platelet-specific counting 3
• Show superior correlation with international reference method (IRM) compared to impedance in thalassemia patients 4
• PLT-O demonstrates strong anti-interference potential and correlates better with microscopy than PLT-I under interference conditions 3
• Enhanced 8× counting mode (PLT-O 8×) provides better repeatability than standard methods in low platelet ranges (10-20-60-100 × 10⁹/L) 3

PLT-I (Traditional Impedance)

• Most susceptible to interference from small RBCs, schistocytes, and blast fragments 1, 5, 4
• Shows lowest correlation with IRM in thalassemia patients 4
• Acceptable sensitivity but low specificity for thrombocytopenia diagnosis 4
• High RDW-CV (red blood cell distribution width-coefficient of variation) is an independent predictor of inaccurate PLT-I measurement 4

Clinical Context-Specific Performance

Anemic Samples

In 583 anemic samples, PLT-H demonstrated markedly better accuracy than PLT-I, with correlation to PLT-F ranging from 0.991 to 0.999 1. The hybrid method particularly excels in thrombocytopenic anemic patients where impedance methods frequently overestimate counts.

Thalassemia Patients

Among 249 thalassemia specimens, PLT-I showed the lowest correlation with IRM, while PLT-O and PLT-F were comparable to the reference method across clinically significant platelet ranges 4. Optical methods are specifically recommended for thalassemia patients due to the high prevalence of small RBCs and elevated RDW-CV.

Acute Hypercellular Leukemias

Both PLT-O and PLT-F have significant limitations in acute leukemias with hyperleukocytosis (>100 × 10⁹/L) and blast fragments 5. In 26% of cases with blast fragments (predominantly AML-M5 and AML-M1 subtypes):

• PLT-I frequently overestimates counts
• PLT-F overestimated platelet numbers in 6 of 16 samples compared to flow cytometry
• PLT-F failed to trigger abnormal scattergram flags in all but one discrepant case
• CD41+/CD61+ flow cytometry remains the most reliable approach when blast fragments are present 5

Practical Implementation Algorithm

Initial Testing Strategy

1. Use PLT-H as first-line method when available - provides impedance-level cost with optical-level accuracy 1, 2
2. If PLT-H unavailable, use PLT-O/PLT-F for:
   • Anemic patients
   • Thalassemia patients
   • Thrombocytopenic samples (PLT <100 × 10⁹/L)
   • High RDW-CV samples

Verification Requirements

• Acute leukemia with hyperleukocytosis: Perform blood smear examination; if blast fragments present, use CD41/CD61 flow cytometry 5
• Discrepant results between methods: Review blood smear and consider immunological platelet counting (CD41/CD61) as reference 2, 5
• Platelet transfusion decisions: PLT-H shows high agreement with reference methods (ICC = 0.972) and superior performance to PLT-I at medical decision levels 2

Cost-Effectiveness Considerations

PLT-H represents the optimal balance of accuracy and cost - it provides optical-level accuracy without requiring additional fluorescent dyes or detectors beyond standard impedance analyzers 1, 2. An intelligent automated workflow using PLT-H as primary method with selective PLT-O reflex testing processed >99% of 1,208 samples accurately, with only 0.25% requiring manual review 6.

Critical Limitations and Pitfalls

Common Pitfalls to Avoid

• Do not rely solely on PLT-I in patients with:

  • Microcytic anemia (MCV <80 fL)
  • High RDW-CV
  • Known thalassemia
  • Acute leukemia with high white cell counts

• Do not assume PLT-F is infallible - it can overestimate counts in hypercellular leukemias with blast fragments and may not flag these interferences 5

• Always perform blood smear examination when:

  • Platelet counts are unexpectedly normal in patients with bleeding symptoms
  • Acute leukemia with WBC >100 × 10⁹/L
  • Discrepancies exist between counting methods

Quality Control Requirements

Flow cytometry consensus guidelines emphasize standardization of pre-analytical variables, with citrate as preferred anticoagulant for platelet testing 7. However, significant uncertainty remains regarding clinical utility of various flow cytometric platelet tests, indicating need for rigorous multicenter outcome studies 7.